MustGrow Biologics Corp. MGROF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 359.58% | -97.28% | 631.92% | 179.92% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 359.58% | -97.28% | 631.92% | 179.92% | -- |
| Cost of Revenue | -51.77% | 153.21% | 491.40% | 693.10% | 604.47% |
| Gross Profit | 1,320.46% | -25.36% | -44.57% | -52.52% | -72.47% |
| SG&A Expenses | 19.77% | -22.51% | 44.71% | 25.70% | -16.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.64% | -4.53% | 83.68% | 58.55% | 24.80% |
| Operating Income | 168.78% | 15.03% | -22.98% | -37.85% | 12.78% |
| Income Before Tax | 143.79% | 33.29% | -73.74% | -43.13% | 2.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 143.79% | 33.29% | -73.74% | -43.13% | 2.88% |
| Earnings from Discontinued Operations | 12.22% | -72.52% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 126.14% | 15.63% | -73.74% | -43.13% | -12.16% |
| EBIT | 168.78% | 15.03% | -22.98% | -37.85% | 12.78% |
| EBITDA | 171.03% | 15.23% | -- | -- | -- |
| EPS Basic | 121.19% | 29.73% | -52.38% | -34.73% | -11.03% |
| Normalized Basic EPS | 135.37% | 44.35% | 0.95% | -35.57% | 3.53% |
| EPS Diluted | 121.19% | 29.73% | -52.38% | -34.73% | -11.03% |
| Normalized Diluted EPS | 135.37% | 44.35% | 0.95% | -35.57% | 3.53% |
| Average Basic Shares Outstanding | 22.51% | 20.07% | 14.06% | 5.94% | 0.94% |
| Average Diluted Shares Outstanding | 22.51% | 20.07% | 14.06% | 5.94% | 0.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |